Cargando…
The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period
OBJECTIVES: In this retrospective study, we present a clinical review of our experience with tongue cancer in order to obtain valid criteria for therapeutic decision-making. MATERIALS AND METHODS: Between 1980 and 2009, a total of 341 patients with squamous cell carcinoma of the tongue were treated...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123311/ https://www.ncbi.nlm.nih.gov/pubmed/21600000 http://dx.doi.org/10.1186/1758-3284-3-27 |
_version_ | 1782206967333257216 |
---|---|
author | Kokemueller, Horst Rana, Majeed Rublack, Jennifer Eckardt, Andre Tavassol, Frank Schumann, Paul Lindhorst, Daniel Ruecker, Martin Gellrich, Nils-Claudius |
author_facet | Kokemueller, Horst Rana, Majeed Rublack, Jennifer Eckardt, Andre Tavassol, Frank Schumann, Paul Lindhorst, Daniel Ruecker, Martin Gellrich, Nils-Claudius |
author_sort | Kokemueller, Horst |
collection | PubMed |
description | OBJECTIVES: In this retrospective study, we present a clinical review of our experience with tongue cancer in order to obtain valid criteria for therapeutic decision-making. MATERIALS AND METHODS: Between 1980 and 2009, a total of 341 patients with squamous cell carcinoma of the tongue were treated at our Department. The average follow-up was 5.2 years. 309 patients received surgical treatment, which was combined in nearly 10% with neoadjuvant and in nearly 20% with postoperative radio(chemo)therapy. 32 patients were excluded from surgery and received primary radiation. RESULTS: Local and regional failure occurred in 23.9% and 20.4%, leading to a total failure rate of 37.2% after an average duration of 1,6 years. N-Status, extracapsular spread and clear margins were identified as the dominant factors for survival, which was calculated with 54.5% after 5 years. CONCLUSIONS: We recommend categorical bilateral neck dissection in order to reliably remove occult lymph node metastases. Adjuvant treatment modalities should be applied more frequently in controlled clinical trials and should generally be implemented in cases with unclear margins and lymphatic spread. CLINICAL RELEVANCE: This study provides new treatment strategies for primary tumour disease and for tumour recurrence. |
format | Online Article Text |
id | pubmed-3123311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31233112011-06-25 The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period Kokemueller, Horst Rana, Majeed Rublack, Jennifer Eckardt, Andre Tavassol, Frank Schumann, Paul Lindhorst, Daniel Ruecker, Martin Gellrich, Nils-Claudius Head Neck Oncol Research OBJECTIVES: In this retrospective study, we present a clinical review of our experience with tongue cancer in order to obtain valid criteria for therapeutic decision-making. MATERIALS AND METHODS: Between 1980 and 2009, a total of 341 patients with squamous cell carcinoma of the tongue were treated at our Department. The average follow-up was 5.2 years. 309 patients received surgical treatment, which was combined in nearly 10% with neoadjuvant and in nearly 20% with postoperative radio(chemo)therapy. 32 patients were excluded from surgery and received primary radiation. RESULTS: Local and regional failure occurred in 23.9% and 20.4%, leading to a total failure rate of 37.2% after an average duration of 1,6 years. N-Status, extracapsular spread and clear margins were identified as the dominant factors for survival, which was calculated with 54.5% after 5 years. CONCLUSIONS: We recommend categorical bilateral neck dissection in order to reliably remove occult lymph node metastases. Adjuvant treatment modalities should be applied more frequently in controlled clinical trials and should generally be implemented in cases with unclear margins and lymphatic spread. CLINICAL RELEVANCE: This study provides new treatment strategies for primary tumour disease and for tumour recurrence. BioMed Central 2011-05-21 /pmc/articles/PMC3123311/ /pubmed/21600000 http://dx.doi.org/10.1186/1758-3284-3-27 Text en Copyright ©2011 Kokemueller et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Kokemueller, Horst Rana, Majeed Rublack, Jennifer Eckardt, Andre Tavassol, Frank Schumann, Paul Lindhorst, Daniel Ruecker, Martin Gellrich, Nils-Claudius The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period |
title | The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period |
title_full | The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period |
title_fullStr | The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period |
title_full_unstemmed | The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period |
title_short | The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period |
title_sort | hannover experience: surgical treatment of tongue cancer - a clinical retrospective evaluation over a 30 years period |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123311/ https://www.ncbi.nlm.nih.gov/pubmed/21600000 http://dx.doi.org/10.1186/1758-3284-3-27 |
work_keys_str_mv | AT kokemuellerhorst thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT ranamajeed thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT rublackjennifer thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT eckardtandre thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT tavassolfrank thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT schumannpaul thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT lindhorstdaniel thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT rueckermartin thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT gellrichnilsclaudius thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT kokemuellerhorst hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT ranamajeed hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT rublackjennifer hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT eckardtandre hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT tavassolfrank hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT schumannpaul hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT lindhorstdaniel hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT rueckermartin hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod AT gellrichnilsclaudius hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod |